{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:30:21Z","timestamp":1785915021420,"version":"3.56.0"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Discov."],"abstract":"<jats:p>Understanding the target and mode of action of compounds identified by phenotypic screening can greatly facilitate the process of drug discovery and development. Here, we outline the tools currently available for target identification against the neglected tropical diseases, human African trypanosomiasis, visceral leishmaniasis and Chagas\u2019 disease. We provide examples how these tools can be used to identify and triage undesirable mechanisms, to identify potential toxic liabilities in patients and to manage a balanced portfolio of target-based campaigns. We review the primary targets of drugs that are currently in clinical development that were initially identified via phenotypic screening, and whose modes of action affect protein turnover, RNA trans-splicing or signalling in these protozoan parasites.<\/jats:p>","DOI":"10.3389\/fddsv.2023.1185679","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T18:23:47Z","timestamp":1683743027000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The critical role of mode of action studies in kinetoplastid drug discovery"],"prefix":"10.3389","volume":"3","author":[{"given":"Alan H.","family":"Fairlamb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wyllie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1093\/emboj\/cdg481","article-title":"Clathrin-mediated endocytosis is essential in Trypanosoma brucei","volume":"22","author":"Allen","year":"2003","journal-title":"EMBO J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0010779","DOI":"10.1371\/journal.pntd.0010779","article-title":"Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response","volume":"16","author":"Alpizar-Sosa","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2012","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1101\/gr.115089.110","article-title":"High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome","volume":"21","author":"Alsford","year":"2011","journal-title":"Genome Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1021\/ar900015x","article-title":"Metalloproteomes: A bioinformatic approach","volume":"42","author":"Andreini","year":"2009","journal-title":"Accounts Chem. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"020955","DOI":"10.1128\/AAC.02095-17","article-title":"Complex interplay between sphingolipid and sterol metabolism revealed by perturbations to the Leishmania metabolome caused by miltefosine","volume":"62","author":"Armitage","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1021\/acschembio.8b00204","article-title":"Metabolic clustering analysis as a strategy for compound selection in the drug discovery pipeline for leishmaniasis","volume":"13","author":"Armitage","year":"","journal-title":"ACS Chem. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.6775372","article-title":"Polyamine metabolism: A potential therapeutic target in trypanosomes","volume":"210","author":"Bacchi","year":"1980","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molbiopara.2010.11.010","article-title":"Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6","volume":"176","author":"Baker","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nbt.1759","article-title":"Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes","volume":"29","author":"Bantscheff","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1128\/AAC.03338-14","article-title":"Drug target identification using a trypanosome overexpression library","volume":"58","author":"Begolo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1007315","DOI":"10.1371\/journal.ppat.1007315","article-title":"The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing","volume":"14","author":"Begolo","year":"2018","journal-title":"PLoS Pathog."},{"key":"B13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/mmi.12374","article-title":"Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure","volume":"90","author":"Berg","year":"2013","journal-title":"Mol. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s1473-3099(22)00660-0","article-title":"Efficacy and safety of acoziborole in patients with human african trypanosomiasis caused by Trypanosoma brucei gambiense: A multicentre, open-label, single-arm, phase 2\/3 trial","volume":"23","author":"Betu Kumeso","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15698\/mic2020.02.708","article-title":"New insights in the mode of action of anti-leishmanial drugs by using chemical mutagenesis screens coupled to next-generation sequencing","volume":"7","author":"Bhattacharya","year":"2020","journal-title":"Microb. Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1038\/s41467-019-13344-6","article-title":"Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania","volume":"10","author":"Bhattacharya","year":"2019","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/nprot.2016.105","article-title":"Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes","volume":"11","author":"Bray","year":"2016","journal-title":"Nature Protocols"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molbiopara.2015.10.004","article-title":"Expanding the tool box for genetic manipulation of Trypanosoma cruzi","volume":"203","author":"Burle-Caldas Gde","year":"2015","journal-title":"Mol. Biochem. Parasitol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e17071","DOI":"10.1038\/cddiscovery.2017.71","article-title":"Zinc-finger proteins in health and disease","volume":"3","author":"Cassandri","year":"2017","journal-title":"Cell Death Discov."},{"key":"B20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: Databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Briefings Bioinforma."},{"key":"B21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1126\/science.986688","article-title":"Trypanosomiasis: An approach to chemotherapy by the inhibition of carbohydrate catabolism","volume":"194","author":"Clarkson","year":"1976","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","article-title":"Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"007955","DOI":"10.1128\/AAC.00795-19","article-title":"Chemogenomic profiling of antileishmanial efficacy and resistance in the related kinetoplastid parasite Trypanosoma brucei","volume":"63","author":"Collett","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev.micro.54.1.129","article-title":"The adaptative mechanisms of Trypanosoma brucei for sterol homeostasis in its different life-cycle environments","volume":"54","author":"Coppens","year":"2000","journal-title":"Annu. Rev. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","article-title":"Pharmacological validation of N-myristoyltransferase as a drug target in Leishmania donovani","volume":"5","author":"Corpas-Lopez","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100704","DOI":"10.1016\/j.xpro.2021.100704","article-title":"Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compounds","volume":"2","author":"Corpas-Lopez","year":"2021","journal-title":"Star. Protoc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"37723","DOI":"10.1074\/jbc.274.53.37723","article-title":"Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression\/selection","volume":"274","author":"Cotrim","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1017\/s0031182013000814","article-title":"Determination of antiprotozoal drug mechanisms by metabolomics approaches","volume":"141","author":"Creek","year":"2014","journal-title":"Parasitology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/jac\/30.6.827","article-title":"The activity of hydroxynaphthoquinones against Leishmania donovani","volume":"30","author":"Croft","year":"1992","journal-title":"J. Antimicrob. Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1021\/ml100013s","article-title":"Discovery of novel benzoxaborole-based potent antitrypanosomal agents","volume":"1","author":"Ding","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"B31","unstructured":"A phase II, multicentre, randomized, two-arm blinded study to assess the efficacy and safety of two LXE408 regimens for treatment of patients with primary visceral leishmaniasis2022"},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molbiopara.2017.06.005","article-title":"Recent advances in Leishmania reverse genetics: Manipulating a manipulative parasite","volume":"216","author":"Duncan","year":"2017","journal-title":"Mol. Biochem. Parasitol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e16092","DOI":"10.1038\/nmicrobiol.2016.92","article-title":"Drug resistance in eukaryotic microorganisms","volume":"1","author":"Fairlamb","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/482167a","article-title":"Infectious disease: Genomics decodes drug action","volume":"482","author":"Fairlamb","year":"2012","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/265270a0","article-title":"New approach to screening drugs for activity against African trypanosomes","volume":"265","author":"Fairlamb","year":"1977","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11306-022-01880-0","article-title":"Trypanosoma brucei: Metabolomics for analysis of cellular metabolism and drug discovery","volume":"18","author":"Fall","year":"2022","journal-title":"Metabolomics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1007\/s11095-011-0586-3","article-title":"Mitochondria and trypanosomatids: Targets and drugs","volume":"28","author":"Fidalgo","year":"2011","journal-title":"Pharm. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/nprot.2015.101","article-title":"Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry","volume":"10","author":"Franken","year":"2015","journal-title":"Nat. Protoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.pt.2007.08.019","article-title":"Target assessment for antiparasitic drug discovery","volume":"23","author":"Frearson","year":"2007","journal-title":"Trends Parasitol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: A large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"E3012","DOI":"10.1073\/pnas.1520693113","article-title":"Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania","volume":"113","author":"Gazanion","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B44","volume-title":"Evaluation of glycogen synthase kinase 3 as a drug target in African trypanosomes","author":"Grimaldi","year":"2014"},{"key":"B45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.str.2005.11.019","article-title":"Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome","volume":"14","author":"Groll","year":"2006","journal-title":"Structure"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/cells10051063","article-title":"Metabolite biomarkers of leishmania antimony resistance","volume":"10","author":"Gutierrez Guarnizo","year":"2021","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.molbiopara.2004.07.007","article-title":"Both of the Rab5 subfamily small GTPases of Trypanosoma brucei are essential and required for endocytosis","volume":"138","author":"Hall","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","article-title":"Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites","volume":"286","author":"Hall","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting knowledge on leishmania drug resistance to support the quest for new drugs","volume":"33","author":"Hefnawy","year":"2017","journal-title":"Trends Parasitol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0326421","DOI":"10.1128\/mbio.03264-21","article-title":"Genomic and phenotypic characterization of experimentally selected resistant Leishmania donovani reveals a role for dynamin-1-like protein in the mechanism of resistance to a novel antileishmanial compound","volume":"13","author":"Hefnawy","year":"2022","journal-title":"mBio"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/microorganisms9081546","article-title":"Experimental selection ofparomomycin resistance in Leishmania donovani amastigotes Iinduces variable genomic polymorphisms","volume":"9","author":"Hendrickx","year":"2021","journal-title":"Microorganisms"},{"key":"B53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s004300100077","article-title":"Use of genetic complementation to identify gene(s) which specify species-specific organ tropism of Leishmania","volume":"190","author":"Hoyer","year":"2001","journal-title":"Med. Microbiol. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/srep02475","article-title":"Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase","volume":"3","author":"Hu","year":"2013","journal-title":"Sci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10264","DOI":"10.1074\/jbc.270.17.10264","article-title":"Rat antizyme inhibits the activity but does not promote the degradation of mouse ornithine decarboxylase in Trypanosoma brucei","volume":"270","author":"Hua","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nmeth.2368","article-title":"Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells","volume":"10","author":"Hulce","year":"2013","journal-title":"Nat. Methods"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 Human African trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ddtec.2006.12.008","article-title":"In silico target fishing: Predicting biological targets from chemical structure","volume":"3","author":"Jenkins","year":"2006","journal-title":"Drug Discov. Today Technol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0004299","DOI":"10.1371\/journal.pntd.0004299","article-title":"Genomic and proteomic studies on the mode of action of oxaboroles against the African trypanosome","volume":"9","author":"Jones","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1003886","DOI":"10.1371\/journal.ppat.1003886","article-title":"Regulators of Trypanosoma brucei cell cycle progression and differentiation identified using a kinome-wide RNAi screen","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog."},{"key":"B61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0166-6851(94)90114-7","article-title":"An approach to functional complementation by introduction of large DNA fragments into Trypanosoma cruzi and Leishmania donovani using a cosmid shuttle vector","volume":"65","author":"Kelly","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e1005058","DOI":"10.1371\/journal.ppat.1005058","article-title":"Utilizing chemical genomics to identify cytochrome b as a novel drug target for Chagas disease","volume":"11","author":"Khare","year":"2015","journal-title":"PLoS Pathog."},{"key":"B64","doi-asserted-by":"publisher","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","article-title":"Open targets: A platform for therapeutic target identification and validation","volume":"45","author":"Koscielny","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nchembio.108","article-title":"A domino effect in antifolate drug action in Escherichia coli","volume":"4","author":"Kwon","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1128\/aac.00642-07","article-title":"The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei","volume":"52","author":"Lanteri","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/b978-0-12-385863-4.00004-6","article-title":"Targeting Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51)","volume":"75","author":"Lepesheva","year":"2011","journal-title":"Adv. Parasitol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2174\/156802611796575902","article-title":"Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis","volume":"11","author":"Lepesheva","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/mcb.12.8.3556","article-title":"Regulated degradation of ornithine decarboxylase requires interaction with the polyamine-inducible protein antizyme","volume":"12","author":"Li","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"42686","DOI":"10.1074\/jbc.M207183200","article-title":"Functional characterization of the 11 non-ATPase subunit proteins in the trypanosome 19 S proteasomal regulatory complex","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e0153521","DOI":"10.1128\/aac.01535-21","article-title":"Identification of a proteasome-targeting arylsulfonamide with potential for the treatment of Chagas' Disease","volume":"66","author":"Lima","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0006612","DOI":"10.1371\/journal.pntd.0006612","article-title":"Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discovery","volume":"12","author":"MacLean","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.drudis.2018.01.050","article-title":"Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum","volume":"23","author":"Manickam","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B74","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","article-title":"The emerging role of mass spectrometry-based proteomics in drug discovery","volume":"21","author":"Meissner","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: The STOP-CHAGAS Trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2174\/138161208784041051","article-title":"Kinetoplast as a potential chemotherapeutic target of trypanosomatids","volume":"14","author":"Motta","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"B78","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/360597a0","article-title":"Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination","volume":"360","author":"Murakami","year":"1992","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1042\/bj2950305","article-title":"Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate","volume":"295","author":"Murakami","year":"1993","journal-title":"Biochem. J."},{"key":"B80","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selectiveproteasome inhibitor for the treatment of leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J. Med. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/13543776.2022.2083502","article-title":"Anticancer carbonic anhydrase inhibitors: A patent and literature update 2018-2022","volume":"32","author":"Nerella","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"B82","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/bj20111849","article-title":"Novel sterol metabolic network of Trypanosoma brucei procyclic and bloodstream forms","volume":"443","author":"Nes","year":"2012","journal-title":"Biochem. J."},{"key":"B83","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/13543776.2018.1473379","article-title":"Benzoxaborole compounds for therapeutic uses: A patent review (2010-2018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"B84","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1128\/AAC.00364-08","article-title":"Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy","volume":"52","author":"Ojo","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B86","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1074\/mcp.m200025-mcp200","article-title":"Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics","volume":"1","author":"Ong","year":"2002","journal-title":"Mol. Cell. Proteomics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1128\/AAC.00850-16","article-title":"Targeting the cytochrome bc1 complex of Leishmania parasites for discovery of novel drugs","volume":"60","author":"Ortiz","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B88","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41589-022-01040-4","article-title":"Expanding the search for small-molecule antibacterials by multidimensional profiling","volume":"18","author":"Ortmayr","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.freeradbiomed.2012.08.568","article-title":"Zinc and the modulation of redox homeostasis","volume":"53","author":"Oteiza","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.chembiol.2021.02.008","article-title":"Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial","volume":"28","author":"Paradela","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s1471-4922(02)00064-8","article-title":"Characterization and role of protozoan parasite proteasomes","volume":"19","author":"Paugam","year":"2003","journal-title":"Trends Parasitol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e8771","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: An open resource","volume":"5","author":"Pe\u00f1a","year":"2015","journal-title":"Sci. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.3389\/fcimb.2018.00325","article-title":"Reverse epidemiology: An experimental framework to drive leishmania biomarker discovery in situ by functional genetic screening using relevant animal models","volume":"8","author":"Piel","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drudis.2011.09.012","article-title":"Hypothesis driven drug design: Improving quality and effectiveness of the design-make-test-analyse cycle","volume":"17","author":"Plowright","year":"2012","journal-title":"Drug Discov. Today"},{"key":"B95","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-4939-9210-2_7","article-title":"Cos-seq: A high-throughput gain-of-function screen for drug resistance studies in Leishmania","volume":"1971","author":"Potvin","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1389202918666170911161311","article-title":"Gene and chromosomal copy number variations as an adaptive mechanism towards a parasitic lifestyle in trypanosomatids","volume":"19","author":"Reis-Cunha","year":"2018","journal-title":"Curr. Genomics"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0004014","DOI":"10.1371\/journal.pntd.0004014","article-title":"Development of a fluorescence-based Trypanosoma cruzi CYP51 inhibition assay for effective compound triaging in drug discovery programmes for Chagas disease","volume":"9","author":"Riley","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/s0166-6851(02)00280-3","article-title":"Fatty acid and sterol metabolism: Potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa","volume":"126","author":"Roberts","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0166-6851(99)00110-3","article-title":"The Leishmania mexicana proteasome","volume":"103","author":"Robertson","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e0130675","DOI":"10.1371\/journal.pone.0130675","article-title":"A multiplatform metabolomic approach to the basis of antimonial action and resistance in Leishmania infantum","volume":"10","author":"Rojo","year":"2015","journal-title":"Plos One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s13071-021-04947-4","article-title":"Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan","volume":"14","author":"Rosa-Teijeiro","year":"2021","journal-title":"Parasites Vectors"},{"key":"B102","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0378-1119(93)90684-u","article-title":"Shuttle cosmid vectors for the trypanosomatid parasite Leishmania","volume":"131","author":"Ryan","year":"1993","journal-title":"Gene"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41564-020-0745-6","article-title":"Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors","volume":"5","author":"Saldivia","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/NCHEMBIO.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jmb.2009.04.073","article-title":"Crystal structures of the human and fungal cytosolic leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaboroles","volume":"390","author":"Seiradake","year":"2009","journal-title":"J. Mol. Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1073\/pnas.87.3.950","article-title":"Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs","volume":"87","author":"Shapiro","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B107","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.mi.49.100195.001001","article-title":"The structure and replication of kinetoplast DNA","volume":"49","author":"Shapiro","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1021\/acsinfecdis.9b00071","article-title":"Antibacterial activity and mode of action of a sulfonamide-based class of oxaborole leucyl-tRNA-synthetase inhibitors","volume":"5","author":"Si","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1021\/acs.jmedchem.1c02104","article-title":"Repositioning of a diaminothiazole series confirmed to target the cyclin-dependent kinase CRK12 for use in the treatment of African animal trypanosomiasis","volume":"65","author":"Smith","year":"2022","journal-title":"J. Med. Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"102002","DOI":"10.1016\/j.xpro.2022.102002","article-title":"Chemical pulldown combined with mass spectrometry to identify the molecular targets of antimalarials in cell-free lysates","volume":"4","author":"Smith","year":"2023","journal-title":"Star. Protoc."},{"key":"B111","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1128\/AAC.00820-16","article-title":"Antimalarial benzoxaboroles target Plasmodium falciparum leucyl-tRNA synthetase","volume":"60","author":"Sonoiki","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e0006450","DOI":"10.1371\/journal.pntd.0006450","article-title":"Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei","volume":"12","author":"Steketee","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"108159","DOI":"10.1016\/j.dib.2022.108159","article-title":"A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides","volume":"42","author":"Tanwar","year":"2022","journal-title":"Data Brief"},{"key":"B114","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-385863-4.00011-3","article-title":"Genetic techniques in Trypanosoma cruzi","volume":"75","author":"Taylor","year":"2011","journal-title":"Adv. Parasitol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrd2410","article-title":"Target deconvolution strategies in drug discovery","volume":"6","author":"Terstappen","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1021\/acs.jmedchem.8b01218","article-title":"Identification of GSK3186899\/DDD853651 as a preclinical development candidate for the treatment of visceral leishmaniasis","volume":"62","author":"Thomas","year":"2019","journal-title":"J. Med. Chem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"9523","DOI":"10.1021\/acs.jmedchem.0c00705","article-title":"Identification and optimization of a series of 8-hydroxy naphthyridines with potent in vitro antileishmanial activity: Initial SAR and assessment of in vivo activity","volume":"63","author":"Thomas","year":"2020","journal-title":"J. Med. Chem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e2844","DOI":"10.1371\/journal.pntd.0002844","article-title":"Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics","volume":"8","author":"Trochine","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1462-5822.2004.00399.x","article-title":"RNA interference in protozoan parasites","volume":"6","author":"Ullu","year":"2004","journal-title":"Cell. Microbiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"7536","DOI":"10.1021\/jm500239b","article-title":"The design and synthesis of potent and selective inhibitors of Trypanosoma brucei glycogen synthase kinase 3 for the treatment of human African trypanosomiasis","volume":"57","author":"Urich","year":"2014","journal-title":"J. Med. Chem."},{"key":"B121","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.pt.2020.06.006","article-title":"Sand fly studies predict transmission potential of drug-resistant leishmania","volume":"36","author":"Van Bockstal","year":"2020","journal-title":"Trends Parasitol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/0035-9203(85)90195-6","article-title":"Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial","volume":"79","author":"Van Nieuwenhove","year":"1985","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B123","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","article-title":"Phenotypic drug discovery: Recent successes, lessons learned and new directions","volume":"21","author":"Vincent","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B124","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1087057114551519","article-title":"Metabolomic-based strategies for anti-parasite drug discovery","volume":"20","author":"Vincent","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e1618","DOI":"10.1371\/journal.pntd.0001618","article-title":"Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei","volume":"6","author":"Vincent","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijpddr.2013.11.002","article-title":"Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism","volume":"4","author":"Vincent","year":"2014","journal-title":"Int. J. Parasitoloy. Drugs Drug Resist."},{"key":"B127","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/acsinfecdis.9b00426","article-title":"The Qi Site of cytochrome b is a promiscuous drug target in Trypanosoma cruzi and Leishmania donovani","volume":"6","author":"Wall","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e00235","DOI":"10.1128\/AAC.00235-18;e00235-18","article-title":"Antitrypanosomal 8-hydroxy-naphthyridnes are chelators of divalent transition metals","volume":"62","author":"Wall","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B129","doi-asserted-by":"publisher","first-page":"9616","DOI":"10.1073\/pnas.1807915115","article-title":"Clinical and veterinary trypanocidal benzoxaboroles target CPSF3","volume":"115","author":"Wall","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B130","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1208\/s12248-012-9449-z","article-title":"TargetHunter: An in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database","volume":"15","author":"Wang","year":"2013","journal-title":"Aaps J."},{"key":"B131","doi-asserted-by":"publisher","first-page":"W623","DOI":"10.1093\/nar\/gkp456","article-title":"PubChem: A public information system for analyzing bioactivities of small molecules","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/cmdc.201300072","article-title":"From on-target to off-target activity: Identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules","volume":"8","author":"Woodland","year":"2013","journal-title":"ChemMedChem"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2174\/156802611795429185","article-title":"Target validation: Linking target and chemical properties to desired product profile","volume":"11","author":"Wyatt","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"B135","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B136","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jac\/dkv376","article-title":"Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei","volume":"71","author":"Wyllie","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e1005971","DOI":"10.1371\/journal.ppat.1005971","article-title":"Activation of bicyclic nitro-drugs by a novel nitroreductase (NTR2) in Leishmania","volume":"12","author":"Wyllie","year":"","journal-title":"PLoS Pathog."},{"key":"B138","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"key":"B139","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s1383-5769(03)00012-6","article-title":"The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice","volume":"52","author":"Yabu","year":"2003","journal-title":"Parasitol. Int."},{"key":"B140","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1128\/aac.01129-16","article-title":"Antileishmanial mechanism of diamidines involves targeting kinetoplasts","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B141","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijpddr.2018.08.002","article-title":"Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number","volume":"8","author":"Yasur-Landau","year":"2018","journal-title":"Int. J. Parasitoloy. Drugs Drug Resist."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.drudis.2021.10.010","article-title":"Deep learning in target prediction and drug repositioning: Recent advances and challenges","volume":"27","author":"Yu","year":"2022","journal-title":"Drug Discov. Today"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e1006850","DOI":"10.1371\/journal.ppat.1006850","article-title":"Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles","volume":"14","author":"Zhang","year":"2018","journal-title":"PLoS Pathog."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1002\/anie.201208749","article-title":"Target identification for small bioactive molecules: Finding the needle in the haystack","volume":"52","author":"Ziegler","year":"2013","journal-title":"Angewandte Chemie-International Ed. Engl."},{"key":"B145","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1074\/jbc.RA120.012355","article-title":"Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes","volume":"295","author":"Zoltner","year":"2020","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Drug Discovery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddsv.2023.1185679\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T18:23:53Z","timestamp":1683743033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fddsv.2023.1185679\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":146,"alternative-id":["10.3389\/fddsv.2023.1185679"],"URL":"https:\/\/doi.org\/10.3389\/fddsv.2023.1185679","relation":{},"ISSN":["2674-0338"],"issn-type":[{"value":"2674-0338","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"article-number":"1185679"}}